DongBao东宝品牌怎么样 申请店铺

我要投票 DongBao东宝在中草药行业中的票数:40 更新时间:2024-12-27
DongBao东宝是哪个国家的品牌?「DongBao东宝」是 通化东宝药业股份有限公司 旗下著名品牌。该品牌发源于吉,由创始人李一奎在1997-09-12期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
DongBao东宝怎么样

通化东宝集团有限公司坐落于中国著名的“医药城”吉林省通化市西郊,集自然美丽风光、历史人文景观、民族医药宝库为一体的兴办企业最佳之地。

1984年,年仅32岁的青年企业家李一奎以他超人的胆识和非凡的魄力,创建了白山滋补品厂。

1992年12月,组建了中国通化东宝集团。其间先后兼并了数家企业,特别是在1992年兼并了集团所在地通化县二密镇恒德村,在国内首创“以企兼农”典型范例,在全国引起强烈反响。集团成立13年来,企业规模发展之猛,多元化项目经营之广,兼并国营民企数量之多,生产设备与工艺流程之先,科研队伍研究水平之高,都堪称国内企业发展之奇迹,被业内人士誉为“东宝模式”,创造了中国企业快速蓬勃发展的神话。

东宝的制药业,以拥有世界上最先进的生物制药尖端技术而备受世人瞩目。先后研制推出了“镇脑宁”,东宝肝泰片、脑血康片等一大批国家级新药和拳头产品。在生物制药领域,集团先后投入数亿元科研经费,于1998年成功研制出具有中国独立知识产权的高科技制剂药品“甘舒霖”,填补了国内空白,使中国继美国、丹麦之后成为世界上第三个能生产基因重组人胰岛素、第二个能生产甘精胰岛素的国家,该成果被587名中国工程院院士评为中国十大科技进展新闻奖。目前,投资总额为3.5亿元的国家振兴东北老工业基地重点扶持项目——东宝基因重组人胰岛素二期扩建工程正在紧张引进和安装国外先进设备,在近两年内将达产3000公斤,满足日益增长的国内和国际市场需求。东宝集团已成为世界上具有相当规模、拥有当今先进技术的人胰岛素生产基地之一。

东宝集团坚持科学发展观,积极构建和谐型企业。1994年集团在扒宝沟建立了全国第一家由企业兴建的自然保护区;1995年先后投入600余万元,修筑507米长的堤坝和拦水坝;2003年初集团通过了国家ISO14001环境管理体系认证;使集团成为“山青、水碧、天蓝”山川秀美的生态型现代化企业,做到了经济效益与生态效益互利双赢。

今天的东宝集团,在全国人大代表、集团董事长李一奎先生的带领下,乘借国家振兴东北老工业基地的春风,励精图治,只争朝夕,为打造中国民族品牌,领跑世界生物制药技术而努力拼搏,阔步前进!

Tonghua Dongbao Group Co., Ltd. is located in the western suburb of Tonghua City, Jilin Province, a famous "medicine city" in China. It is the best place to set up an enterprise integrating natural beautiful scenery, historical and cultural landscape, and national medicine treasure house. In 1984, Li Yikui, a 32-year-old young entrepreneur, founded Baishan tonic factory with his superhuman courage and extraordinary courage. In December 1992, China Tonghua Dongbao group was established. During this period, several enterprises were merged successively, especially Hengde village, Ermi Town, Tonghua County, where the group is located in 1992. It is the first typical example of "combining enterprise with agriculture" in China, which has aroused strong repercussions all over the country. In the past 13 years since the establishment of the group, the rapid development of the enterprise scale, the wide diversification of project management, the large number of state-owned private enterprises to be merged, the first production equipment and technological process, and the high research level of scientific research team have all been regarded as the miracle of the development of domestic enterprises, known as the "Oriental model" by the insiders, and created the myth of the rapid and vigorous development of Chinese enterprises. Dongbao's pharmaceutical industry, with the most advanced biopharmaceutical technology in the world, has attracted worldwide attention. A large number of state-level new drugs and blockbuster products, such as "zhennaoning", Dongbao Gantai tablet, Naoxuekang tablet, have been developed and launched successively. In the field of biopharmaceutical, the group has successively invested hundreds of millions of yuan in scientific research funds. In 1998, the group successfully developed "gansulin", a high-tech pharmaceutical preparation with independent intellectual property rights in China, which filled in the domestic gap. After the United States and Denmark, China has become the third country in the world that can produce recombinant human insulin and the second country that can produce insulin glargine. This achievement has been ranked 587 in China Academicians of the Chinese Academy of Engineering awarded the top ten science and technology progress News Awards. At present, the second phase expansion project of Dongbao gene recombinant human insulin, a key supporting project for revitalizing the old industrial base in Northeast China with a total investment of 350 million yuan, is urgently introducing and installing foreign advanced equipment, which will reach a production capacity of 3000 kg in recent two years, meeting the growing domestic and international market demand. Dongbao group has become one of the human insulin production bases with considerable scale and advanced technology in the world. Dongbao group adheres to the scientific concept of development and actively constructs a harmonious enterprise. In 1994, the group established the first enterprise built Nature Reserve in babaogou; in 1995, it invested more than 6 million yuan to build 507 meter long dams and dams; at the beginning of 2003, the group passed the national ISO14001 environmental management system certification; the group became an ecological modern enterprise with beautiful mountains and rivers, achieving economic and ecological benefits Mutual benefit and win-win situation. Today's Dongbao group, under the leadership of Mr. Li Yikui, deputy to the National People's Congress and chairman of the group, takes advantage of the spring breeze of the country's revitalization of the old industrial base in Northeast China, makes every effort to build a Chinese national brand and lead the world's biopharmaceutical technology, and makes great progress!

本文链接: https://brand.waitui.com/f89fb8898.html

千城特选小程序码

7×24h 快讯

沪深两市成交额连续第63个交易日突破1万亿

36氪获悉,沪深两市成交额连续第63个交易日突破1万亿,较上日此时放量近1100亿。

21分钟前

日本政府通过温室气体减排新目标:2035年度较2013年度减排60%

据报道,日本政府12月27日召开全球变暖对策推进总部(总部长:首相石破茂)会议,通过了全球变暖对策计划的修改方案,其中提出“2035年度较2013年度减排60%、2040年度减排73%”的温室气体减排新目标。日本政府将在征求公众意见后,在内阁会议上敲定修改方案,并力争在2025年2月底前向联合国汇报。(界面)

21分钟前

南京公用宣布并购,股价“提前”涨停,公司最新回应

26日晚间,南京公用公告,公司拟购买宇谷科技约68%股权并募集配套资金。本次交易预计不构成重大资产重组,不构成重组上市。公司股票自12月27日开市起停牌,预计不超过10个交易日。公告当日,该股录得涨停。对此,南京公用相关人士表示,公司主营能源业务,以传统燃气为主。同时也在布局新能源领域,包括充电桩业务等,不过体量尚小。目前相关事宜处于初步商谈阶段,后续情况以公司公告为准。关于股价“提前”涨停,前述人士表示,公司股价近期涨跌频繁,不清楚昨日涨停原因。交易双方不存在内幕消息泄露的情形。(21财经)

21分钟前

力箭一号遥六民营商业运载火箭飞行试验任务失利

12月27日9时3分,力箭一号遥六民营商业运载火箭在东风商业航天创新试验区点火升空,火箭飞行异常,飞行试验任务失利。具体原因正在进一步分析排查。(新华社)

21分钟前

韩国央行:超三成韩国人持有加密货币

韩国央行根据在Upbit、Bithumb、Coin One、Cobit和Gopax等五大韩国交易所拥有账户的投资者数量统计发布报告称,截至今年11月,在韩国交易所持有加密货币的人数超过1559万人,比10月份的1498万人增加了61万人。目前,韩国总人口预计在5123万人左右。这意味着,持有加密货币的人口数量相当于总人口的30%以上。报告称,韩国加密货币投资者的数量一直在上升,而在11月更是直线飙升。(财联社)

21分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询